8-K: Avalon GloboCare Executes Preferred Stock Exchange and Files Series D Designation

Avalon GloboCare Corp. finalized an exchange agreement with its Chairman, Wenzhao Lu, involving preferred stock, and filed the designation for its Series D Convertible Preferred Stock.

Summary

• Avalon GloboCare Corp. entered into an exchange agreement with Wenzhao Lu, the Chairman of the Board, on January 9, 2025.
• Lu exchanged 9,000 shares of Series A Preferred Stock for 5,000 shares of Series D Preferred Stock.
• This exchange was executed under an exemption from registration according to Section 3(a)(9) of the Securities Act of 1933.
• Following the exchange, there are no remaining shares of Series A Preferred Stock outstanding.
• On January 6, 2025, the company filed a certificate of designations for Series D Convertible Preferred Stock with the Delaware Department of State.
• This designation authorizes 5,000 shares of Series D Preferred Stock with a par value of $0.0001 per share.
• Each share of Series D Preferred Stock has a stated value of $1,000.
• Series D Preferred Stock ranks senior to common stock and any future junior stock, pari passu with other preferred stock series (B and C).
• Holders of Series D Preferred Stock have limited voting power, as required by Delaware law.
• In the event of liquidation, Series D holders are entitled to receive 100% of the stated value before common stockholders.
• Each Series D share is convertible into common stock at a conversion price of $2.41, pending shareholder approval from Nasdaq.
• Conversion is limited to ensure no holder exceeds 4.99% beneficial ownership of common stock after conversion.

Sentiment

Score: 6

Explanation: The document describes a routine corporate action (stock exchange and designation). While the terms are clearly defined, the overall sentiment is neutral as it lacks significant positive or negative implications without further context.

Positives

• The exchange simplifies the company's capital structure by eliminating the Series A Preferred Stock.
• The Series D Preferred Stock designation provides clear terms and conditions for the new preferred shares.
• The conversion feature offers potential upside for holders of Series D Preferred Stock, pending shareholder approval.
• The beneficial ownership limitation protects against excessive concentration of ownership.

Negatives

• The Series D Preferred Stock holders have limited voting rights, which could reduce shareholder influence.
• The conversion of Series D Preferred Stock into common stock is contingent upon shareholder approval, creating uncertainty.
• The conversion is capped to prevent any holder from exceeding 4.99% beneficial ownership of common stock, which may limit potential gains.

Risks

• The company's ability to obtain shareholder approval for the issuance of conversion shares is uncertain.
• The conversion price of $2.41 may be unfavorable if the company's stock price declines.
• The beneficial ownership limitation may deter some investors from converting their Series D Preferred Stock.
• The company's financial performance could impact the value of the Series D Preferred Stock and its conversion potential.

Future Outlook

The document outlines the terms and conditions of the Series D Preferred Stock and its potential conversion into common stock, pending shareholder approval. The future impact depends on the company's performance, market conditions, and shareholder decisions.

Management Comments

• The document does not contain direct quotes, but it implies management believes the exchange and Series D designation are in the best interests of the company.

Industry Context

Companies often use preferred stock to raise capital or restructure their balance sheets. The terms of the Series D Preferred Stock, including the conversion price and liquidation preferences, are typical features of such securities. The exchange with the Chairman suggests a strategic move to simplify the capital structure.

Comparison to Industry Standards

• The terms of Avalon GloboCare's Series D Preferred Stock, such as liquidation preferences and conversion rights, are generally consistent with industry standards for preferred stock offerings.
• The conversion price of $2.41 will need to be compared to the market price of Avalon GloboCare's common stock to assess its attractiveness to investors.
• Similar companies, such as those in the biotechnology or healthcare sectors, often use preferred stock to fund research and development or acquisitions.
• The beneficial ownership limitation of 4.99% is a common provision to prevent hostile takeovers or undue influence by a single investor.

Related Party Transactions

• The exchange agreement with Wenzhao Lu, the Chairman of the Board, constitutes a related-party transaction.

Stakeholder Impact

• Shareholders may be affected by the potential dilution from the conversion of Series D Preferred Stock.
• The exchange simplifies the company's capital structure, which could benefit all stakeholders.
• The terms of the Series D Preferred Stock could impact the company's ability to raise capital in the future.

Next Steps

• Obtain shareholder approval for the issuance of conversion shares.
• Monitor the company's stock price to assess the attractiveness of the conversion option.
• Comply with all regulatory requirements related to the exchange and designation.

Key Dates